Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decompartmentalizing target validation-thinking outside the pipeline boxes

Rob Hooft van Huijsduijnen1, Christian Rommel

  • 1Serono Pharmaceutical Research Institute, Serono International S.A., 14, Chemin des Aulx, 1228, Plan-les-Ouates, Geneva, Switzerland.

Journal of Molecular Medicine (Berlin, Germany)
|August 23, 2006
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks.

ACS infectious diseases·2022
Same author

Reassessing therapeutic antibodies for neglected and tropical diseases.

PLoS neglected tropical diseases·2020
Same author

Two successful decades of Swiss collaborations to develop new anti-malarials.

Malaria journal·2019
Same author

A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria.

Malaria journal·2018
Same author

Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria.

Malaria journal·2018
Same author

Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study.

The Lancet. Infectious diseases·2018